Corient Private Wealth’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $13.6M | Buy |
194,563
+7,409
| +4% | +$518K | 0.01% | 504 |
|
|
2025
Q1 | $13.8M | Sell |
187,154
-10,103
| -5% | -$743K | 0.02% | 451 |
|
|
2024
Q4 | $12.6M | Buy |
197,257
+8,894
| +5% | +$570K | 0.02% | 464 |
|
|
2024
Q3 | $14.7M | Sell |
188,363
-17,090
| -8% | -$1.33M | 0.02% | 457 |
|
|
2024
Q2 | $16M | Buy |
205,453
+57,809
| +39% | +$4.51M | 0.03% | 430 |
|
|
2024
Q1 | $10M | Sell |
147,644
-158,483
| -52% | -$10.7M | 0.02% | 522 |
|
|
2023
Q4 | $20.6M | Sell |
306,127
-53,716
| -15% | -$3.62M | 0.04% | 381 |
|
|
2023
Q3 | $24.4M | Buy |
359,843
+136,583
| +61% | +$9.25M | 0.06% | 303 |
|
|
2023
Q2 | $16M | Sell |
223,260
-44
| -0% | -$3.15K | 0.04% | 387 |
|
|
2023
Q1 | $15.5M | Buy |
223,304
+28,836
| +15% | +$2M | 0.04% | 360 |
|
|
2022
Q4 | $13.2M | Buy |
+194,468
| New | +$13.2M | 0.05% | 325 |
|